CD BioGlyco, a leading biotechnology company specializing in glycobiology, is proud to announce its enhanced polysaccharide vaccine development services. Leveraging cutting-edge platforms and extensive expertise, CD BioGlyco is poised to support researchers and organizations in the development of safer, more effective vaccines against a wide range of infectious diseases.
Polysaccharides, complex carbohydrates found on the surface of many bacteria, represent excellent targets for vaccine ...
17 views
0 likes